Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.62
-0.29 (-3.67%)
May 13, 2025, 4:00 PM - Market closed
Cullinan Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 76.66 | 83.01 | 98.43 | 156.15 | 59.77 | 168.2 | Upgrade
|
| Short-Term Investments | 227.17 | 315.97 | 368.63 | 311.14 | 230.69 | 42.01 | Upgrade
|
| Cash & Short-Term Investments | 303.83 | 398.98 | 467.07 | 467.29 | 290.47 | 210.21 | Upgrade
|
| Cash Growth | -29.83% | -14.58% | -0.05% | 60.88% | 38.18% | 113.13% | Upgrade
|
| Other Receivables | - | 6.46 | - | - | - | - | Upgrade
|
| Receivables | - | 6.46 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 13.95 | 9.23 | 13.12 | 7.18 | 6.1 | 2.07 | Upgrade
|
| Total Current Assets | 317.77 | 414.67 | 480.19 | 474.47 | 296.56 | 212.28 | Upgrade
|
| Property, Plant & Equipment | 2.16 | 2.35 | 3.53 | 5.3 | 0.08 | 0.13 | Upgrade
|
| Long-Term Investments | 259.39 | 204.44 | - | 80.88 | 140.4 | - | Upgrade
|
| Other Long-Term Assets | 0.37 | 0.37 | 0.46 | 0.46 | 0.15 | 2.3 | Upgrade
|
| Total Assets | 579.68 | 621.82 | 484.18 | 561.12 | 437.19 | 214.71 | Upgrade
|
| Accounts Payable | 3.4 | 1.68 | 2.49 | 2.66 | 3.17 | 9.68 | Upgrade
|
| Accrued Expenses | 19.81 | 26.23 | 23.29 | 12 | 7.6 | 4.64 | Upgrade
|
| Short-Term Debt | - | - | - | 0.18 | - | - | Upgrade
|
| Current Portion of Leases | 1.35 | 1.3 | 1.44 | 1.42 | - | - | Upgrade
|
| Current Income Taxes Payable | - | - | - | 4.28 | - | - | Upgrade
|
| Other Current Liabilities | 2.8 | 1.44 | 0.91 | 1.96 | 0.97 | - | Upgrade
|
| Total Current Liabilities | 27.35 | 30.65 | 28.14 | 22.5 | 11.75 | 14.32 | Upgrade
|
| Long-Term Leases | 0.49 | 0.85 | 2.15 | 3.59 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.07 | 0.07 | Upgrade
|
| Total Liabilities | 27.84 | 31.5 | 30.29 | 26.09 | 11.81 | 14.39 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 968.07 | 958.7 | 654.69 | 585.32 | 584.71 | 292.35 | Upgrade
|
| Retained Earnings | -416.74 | -368.24 | -200.86 | -47.7 | -158.91 | -93.34 | Upgrade
|
| Comprehensive Income & Other | 0.51 | -0.13 | -0.13 | -2.6 | -0.84 | -0 | Upgrade
|
| Total Common Equity | 551.84 | 590.33 | 453.7 | 535.03 | 424.97 | 199.01 | Upgrade
|
| Minority Interest | - | - | 0.19 | - | 0.4 | 1.3 | Upgrade
|
| Shareholders' Equity | 551.84 | 590.33 | 453.9 | 535.03 | 425.37 | 200.31 | Upgrade
|
| Total Liabilities & Equity | 579.68 | 621.82 | 484.18 | 561.12 | 437.19 | 214.71 | Upgrade
|
| Total Debt | 1.84 | 2.15 | 3.59 | 5.19 | - | - | Upgrade
|
| Net Cash (Debt) | 301.99 | 396.83 | 463.48 | 462.1 | 290.47 | 210.21 | Upgrade
|
| Net Cash Growth | -29.74% | -14.38% | 0.30% | 59.09% | 38.18% | 113.13% | Upgrade
|
| Net Cash Per Share | 5.23 | 7.38 | 11.15 | 9.91 | 6.74 | 10.57 | Upgrade
|
| Filing Date Shares Outstanding | 59.01 | 58.51 | 43.07 | 39.33 | 44.61 | 43.52 | Upgrade
|
| Total Common Shares Outstanding | 58.7 | 58.51 | 42.9 | 45.8 | 44.29 | 2.02 | Upgrade
|
| Working Capital | 290.42 | 384.02 | 452.05 | 451.97 | 284.82 | 197.96 | Upgrade
|
| Book Value Per Share | 9.40 | 10.09 | 10.58 | 11.68 | 9.59 | 98.36 | Upgrade
|
| Tangible Book Value | 551.84 | 590.33 | 453.7 | 535.03 | 424.97 | 199.01 | Upgrade
|
| Tangible Book Value Per Share | 9.40 | 10.09 | 10.58 | 11.68 | 9.59 | 98.36 | Upgrade
|
| Machinery | - | 0.77 | 0.77 | 0.68 | 0.2 | 0.2 | Upgrade
|
| Leasehold Improvements | - | 0.58 | 0.58 | 0.63 | 0.11 | 0.11 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.